C. Manegold

Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapy

V. Trillet-Lenoir, J. Green, C. Manegold et al. · European Journal of Cancer · 1993 · 545 citations

Hematological Malignancy, Granulocyte, Medicine +11

Three-Arm Randomized Study of Two Cisplatin-Based Regimens and Paclitaxel Plus Gemcitabine in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial of the European Organization for Research and Treatment of Cancer Lung Cancer Group—EORTC 08975

Egbert F. Smit, J.P.A.M van Meerbeeck, P. Lianes et al. · Journal of Clinical Oncology · 2003 · 351 citations

Treatment outcome and prognostic factors for primary mediastinal (thymic) B-cell lymphoma: a multicenter study of 106 patients.

Mario Lazzarino, Ester Orlandi, Marco Paulli et al. · Journal of Clinical Oncology · 1997 · 174 citations

A phase II study of gemcitabine in patients with malignant pleural mesothelioma

Jan P. van Meerbeeck, Paul Baas, C. Debruyne et al. · Cancer · 1999 · 135 citations

Phase Ii Study, Pleural Effusion, Pharmacotherapy +16

Single-agent gemcitabine versus cisplatin-etoposide: Early results of a randomised phase II study in locally advanced or metastatic non-small-cell lung cancer

C. Manegold, Bengt Bergman, A. Chemaissani et al. · Annals of Oncology · 1997 · 114 citations · Full text

Medicine, Single-agent Gemcitabine, Metronomic Therapy +7